ATE187068T1 - MICROGRANULES CONTAINING 5-NITROIMIDAZOLE DERIVATIVES - Google Patents

MICROGRANULES CONTAINING 5-NITROIMIDAZOLE DERIVATIVES

Info

Publication number
ATE187068T1
ATE187068T1 AT95907683T AT95907683T ATE187068T1 AT E187068 T1 ATE187068 T1 AT E187068T1 AT 95907683 T AT95907683 T AT 95907683T AT 95907683 T AT95907683 T AT 95907683T AT E187068 T1 ATE187068 T1 AT E187068T1
Authority
AT
Austria
Prior art keywords
microgranules
medicinal
nitroimidazole derivatives
microgranules containing
hand
Prior art date
Application number
AT95907683T
Other languages
German (de)
Inventor
Gerard Leduc
Patrice Debregeas
Original Assignee
Ethypharm Lab Prod Ethiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9400394A external-priority patent/FR2715067B1/en
Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques
Application granted granted Critical
Publication of ATE187068T1 publication Critical patent/ATE187068T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Medicinal form contains a combination of microgranules of derivatives 5-nitroimidasole, consisting, on the one hand, of gastro-resistant microgranules and, on the other hand, of microgranules with a prolonged release of a medicinal agent. Gastroresistant microgranules are intended to guarantee the efficiency of the medicinal form of the present invention, primarily, in the upper part of gastrointestinal tract, while the microgranules with a prolonged medicinal agent release are operate mainly in the lower part of gastrointestinal tract.
AT95907683T 1994-01-14 1995-01-12 MICROGRANULES CONTAINING 5-NITROIMIDAZOLE DERIVATIVES ATE187068T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9400394A FR2715067B1 (en) 1994-01-14 1994-01-14 New dosage form of 5-nitro-imidazole derivatives effective for the treatment of parasitic infections and infections of the entire gastrointestinal tract.

Publications (1)

Publication Number Publication Date
ATE187068T1 true ATE187068T1 (en) 1999-12-15

Family

ID=9459066

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95907683T ATE187068T1 (en) 1994-01-14 1995-01-12 MICROGRANULES CONTAINING 5-NITROIMIDAZOLE DERIVATIVES

Country Status (19)

Country Link
JP (1) JPH09507499A (en)
KR (1) KR100320140B1 (en)
CN (1) CN1088357C (en)
AT (1) ATE187068T1 (en)
AU (1) AU705570B2 (en)
BR (1) BR9506507A (en)
CZ (1) CZ286080B6 (en)
DE (1) DE69513632T2 (en)
DK (1) DK0739201T3 (en)
ES (1) ES2139883T3 (en)
MA (1) MA23429A1 (en)
MX (1) MX9602772A (en)
NZ (1) NZ279238A (en)
OA (1) OA10583A (en)
PL (1) PL178424B1 (en)
PT (1) PT739201E (en)
RU (1) RU2152212C1 (en)
SK (1) SK282066B6 (en)
UA (1) UA28031C2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4331930B2 (en) * 2001-10-17 2009-09-16 武田薬品工業株式会社 High content granules of acid labile drugs
CA2959414C (en) 2014-09-05 2023-03-14 Symbiomix Therapeutics, Llc Secnidazole for use in the treatment of bacterial vaginosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
DE3822095A1 (en) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab NEW MEDICAMENT FORMULATION AND METHOD FOR THE PRODUCTION THEREOF
WO1991017744A1 (en) * 1990-05-14 1991-11-28 Jernberg Gary R Surgical implant and method incorporating chemotherapeutic agents

Also Published As

Publication number Publication date
OA10583A (en) 2002-07-10
DE69513632T2 (en) 2000-04-06
PL315530A1 (en) 1996-11-12
UA28031C2 (en) 2000-10-16
MA23429A1 (en) 1995-10-01
CN1088357C (en) 2002-07-31
RU2152212C1 (en) 2000-07-10
PT739201E (en) 2000-05-31
DK0739201T3 (en) 2000-05-01
ES2139883T3 (en) 2000-02-16
JPH09507499A (en) 1997-07-29
CZ205596A3 (en) 1996-10-16
SK282066B6 (en) 2001-10-08
KR100320140B1 (en) 2002-07-02
NZ279238A (en) 1998-03-25
AU705570B2 (en) 1999-05-27
MX9602772A (en) 1997-05-31
PL178424B1 (en) 2000-04-28
SK91496A3 (en) 1996-12-04
CZ286080B6 (en) 2000-01-12
DE69513632D1 (en) 2000-01-05
AU1580395A (en) 1995-08-01
CN1138826A (en) 1996-12-25
BR9506507A (en) 1997-09-09

Similar Documents

Publication Publication Date Title
MX9707334A (en) Pharmaceutical composition containing selected lanthanum carbonate hydrates.
FR15C0024I2 (en) 6-SUBSTITUTED INDOLINONES, THEIR PREPARATION AND THEIR USE AS MEDICINES
ID21115A (en) ISOQUUOLOL-3-CARBOXAMIDE CHARACTERIZED, PRODUCTION AND USE AS A MEDICINE
DE69829008D1 (en) Nose, mouth and throat cannula
TR199800602A3 (en) Dithiolan derivatives, their preparation and therapeutic effects.
NO308854B1 (en) Therapeutic Compounds, Pharmaceutically Acceptable Salts and Formulations Containing the Compounds, and Uses thereof
DE69836514D1 (en) Electrode body, provided with this accumulator, and production of the electrode body and the accumulator
YU29901A (en) Utilisation of dialkylfumarates
HK1036408A1 (en) Indolyl-3-glyoxylic acid derivatives with antitumoral activity.
PL345852A1 (en) Benzimidazoles, production thereof and use thereof as medicaments
DE60023107D1 (en) PREPARATIONS WITH IMPROVED CONTROLLED RELEASE
IL126714A (en) Use of cells, organs or components thereof for the preparation of a pharmaceutical composition for establishing selective immune downregulation
MXPA03000644A (en) Novel indole derivatives and their use as medicaments.
TR200503846T2 (en) Alternative use for modified release insulin sensitiser and use
ATE187068T1 (en) MICROGRANULES CONTAINING 5-NITROIMIDAZOLE DERIVATIVES
EA199900963A1 (en) MEDICAL FORMS OF SERTRALIN IN THE FORM OF A SOLUTION CONCLUDED IN GELATINIC CAPSULES
EE200000207A (en) 8-Azabicyclo [3.2.1] octane-3-methanamine derivatives, their preparation and therapeutic use
DE68906245D1 (en) THERAPEUTIC AGENT AGAINST AIDS.
NZ501832A (en) Angiotensin-peptide carrier conjugates for treating diseases associated with the renin-angiotensin system
HK1045514A1 (en) Optically pure camptothecin analogues and composition and use thereof.
WO1999020259A3 (en) Compositions containing thiamphenicol and diclofenac
BR9907195A (en) "prolonged-release tiagabine formulations with reduced side effects"
RU96115480A (en) MEDICINAL PREPARED WITH CHOLOLYTOLITIC ACTION
MY128686A (en) Pharmaceutical composition containing selected lanthanum carbonate hydrates
TR28011A (en) Purified / pure streptogramin and its preparation.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee